{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/328666334"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "20090275563Combination of 5-HT7 Receptor Antagonist and Serotonin Reuptake Inhibitor Therapy - Patients suffering from serotonin-mediated diseases or conditions, such as depression, may be treated by administering an effective combined amount of a 5-HT7 receptor antagonist and a serotonin reuptake inhibitor.11-05-2009" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "faqs.org" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/192676611"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/328666334"] } } }
